Sharp Healthcare
San Diego, California 92823
2 studies enrolling now · 31 studies all time
What they study most
Acute Coronary Syndrome, Advanced Cancer, Advanced Solid Tumor, Advanced/Metastatic Solid Tumors, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Breast Tumor, COVID, CRC, Cancer, Cancer Metastatic, Clear Cell Renal Carcinoma, Colon Tumor, Malignant
Studies at this site
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
- Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers — Recruiting now
- Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer — Recruiting now
- Study of DF1001 in Patients With Advanced Solid Tumors — Completed
- A Multicenter Study to Evaluate Functional Outcome After Knee Replacement — Stopped early
- Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). — Completed
- Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
- A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer — Completed
- Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation — Completed
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
- Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile — Completed
- Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
- Tailored Antiplatelet Therapy Following PCI — Completed
- TroVax Renal Immunotherapy Survival Trial — Completed
- Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
- Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer — Withdrawn before enrolling
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients — Completed
- Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer — Completed
- Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool. — Withdrawn before enrolling
- Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy — Completed
- A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
- A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma — Completed
- Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma — Completed
- A Single Patient IND for PD-0325901 — NO_LONGER_AVAILABLE
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
- Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer — Stopped early
- Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) — Completed
- Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
- ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere — Status unconfirmed
- GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer — Stopped early
- Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients — Stopped early